Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis.
In a double-blind, randomized study, 0.05% clobetasone butyrate cream was found to be as effective as 0.1% betamethasone valerate in the treatment of 48 patients with atopic or contact dermatitis, after 2 weeks as well as after 4 weeks of treatment. Side-effects with both drugs were rare and mild.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002990:Clobetasol / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003877:Dermatitis, Contact / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
C010893:clobetasone butyrate; D001623:Betamethasone; D001624:Betamethasone Valerate; D002990:Clobetasol